Global Antibody Drug Conjugate Market Research Report 2017

August 2017 | 110 pages | ID: G118E8C25C5EN
QYResearch

Abstracts

In this report, the global Antibody Drug Conjugate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antibody Drug Conjugate in these regions, from 2012 to 2022 (forecast), covering

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Global Antibody Drug Conjugate market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Seattle Genetics/Takeda
• Roche
• ImmunoGen
• Immunomedics
• Pfizer
• Celldex Therapeutics
• Millennium Pharmaceuticals
• Bayer HealthCare
• Mersana Therapeutics
• Heidelberg Pharma
• Oxford BioTherapeutics
• Takeda Pharmaceutical Company Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Adcetris
• Kadcyl
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Antibody Drug Conjugate for each application, including

• Hospital
• Pharmaceutical Company
• Research Institutions

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Antibody Drug Conjugate Market Research Report 2017

1 ANTIBODY DRUG CONJUGATE MARKET OVERVIEW

1.1 Product Overview and Scope of Antibody Drug Conjugate
1.2 Antibody Drug Conjugate Segment by Type (Product Category)
  1.2.1 Global Antibody Drug Conjugate Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
  1.2.2 Global Antibody Drug Conjugate Production Market Share by Type (Product Category) in 2016
  1.2.3 Adcetris
  1.2.4 Kadcyl
  1.2.5 Other
1.3 Global Antibody Drug Conjugate Segment by Application
  1.3.1 Antibody Drug Conjugate Consumption (Sales) Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Pharmaceutical Company
  1.3.4 Research Institutions
1.4 Global Antibody Drug Conjugate Market by Region (2012-2022)
  1.4.1 Global Antibody Drug Conjugate Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
  1.4.2 North America Status and Prospect (2012-2022)
  1.4.3 Europe Status and Prospect (2012-2022)
  1.4.4 China Status and Prospect (2012-2022)
  1.4.5 Japan Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Status and Prospect (2012-2022)
  1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Antibody Drug Conjugate (2012-2022)
  1.5.1 Global Antibody Drug Conjugate Revenue Status and Outlook (2012-2022)
  1.5.2 Global Antibody Drug Conjugate Capacity, Production Status and Outlook (2012-2022)

2 GLOBAL ANTIBODY DRUG CONJUGATE MARKET COMPETITION BY MANUFACTURERS

2.1 Global Antibody Drug Conjugate Capacity, Production and Share by Manufacturers (2012-2017)
  2.1.1 Global Antibody Drug Conjugate Capacity and Share by Manufacturers (2012-2017)
  2.1.2 Global Antibody Drug Conjugate Production and Share by Manufacturers (2012-2017)
2.2 Global Antibody Drug Conjugate Revenue and Share by Manufacturers (2012-2017)
2.3 Global Antibody Drug Conjugate Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution, Sales Area and Product Type
2.5 Antibody Drug Conjugate Market Competitive Situation and Trends
  2.5.1 Antibody Drug Conjugate Market Concentration Rate
  2.5.2 Antibody Drug Conjugate Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL ANTIBODY DRUG CONJUGATE CAPACITY, PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Antibody Drug Conjugate Capacity and Market Share by Region (2012-2017)
3.2 Global Antibody Drug Conjugate Production and Market Share by Region (2012-2017)
3.3 Global Antibody Drug Conjugate Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL ANTIBODY DRUG CONJUGATE SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGION (2012-2017)

4.1 Global Antibody Drug Conjugate Consumption by Region (2012-2017)
4.2 North America Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
4.3 Europe Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
4.4 China Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
4.5 Japan Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)
4.7 India Antibody Drug Conjugate Production, Consumption, Export, Import (2012-2017)

5 GLOBAL ANTIBODY DRUG CONJUGATE PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Antibody Drug Conjugate Production and Market Share by Type (2012-2017)
5.2 Global Antibody Drug Conjugate Revenue and Market Share by Type (2012-2017)
5.3 Global Antibody Drug Conjugate Price by Type (2012-2017)
5.4 Global Antibody Drug Conjugate Production Growth by Type (2012-2017)

6 GLOBAL ANTIBODY DRUG CONJUGATE MARKET ANALYSIS BY APPLICATION

6.1 Global Antibody Drug Conjugate Consumption and Market Share by Application (2012-2017)
6.2 Global Antibody Drug Conjugate Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL ANTIBODY DRUG CONJUGATE MANUFACTURERS PROFILES/ANALYSIS

7.1 Seattle Genetics/Takeda
  7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.1.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Seattle Genetics/Takeda Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.1.4 Main Business/Business Overview
7.2 Roche
  7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.2.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Roche Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.2.4 Main Business/Business Overview
7.3 ImmunoGen
  7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.3.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 ImmunoGen Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.3.4 Main Business/Business Overview
7.4 Immunomedics
  7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.4.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Immunomedics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.4.4 Main Business/Business Overview
7.5 Pfizer
  7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.5.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Pfizer Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.5.4 Main Business/Business Overview
7.6 Celldex Therapeutics
  7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.6.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Celldex Therapeutics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.6.4 Main Business/Business Overview
7.7 Millennium Pharmaceuticals
  7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.7.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Millennium Pharmaceuticals Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.7.4 Main Business/Business Overview
7.8 Bayer HealthCare
  7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.8.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Bayer HealthCare Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.8.4 Main Business/Business Overview
7.9 Mersana Therapeutics
  7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.9.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Mersana Therapeutics Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.9.4 Main Business/Business Overview
7.10 Heidelberg Pharma
  7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  7.10.2 Antibody Drug Conjugate Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Heidelberg Pharma Antibody Drug Conjugate Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
  7.10.4 Main Business/Business Overview
7.11 Oxford BioTherapeutics
7.12 Takeda Pharmaceutical Company Limited

8 ANTIBODY DRUG CONJUGATE MANUFACTURING COST ANALYSIS

8.1 Antibody Drug Conjugate Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Antibody Drug Conjugate

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Antibody Drug Conjugate Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL ANTIBODY DRUG CONJUGATE MARKET FORECAST (2017-2022)

12.1 Global Antibody Drug Conjugate Capacity, Production, Revenue Forecast (2017-2022)
  12.1.1 Global Antibody Drug Conjugate Capacity, Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Antibody Drug Conjugate Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Antibody Drug Conjugate Price and Trend Forecast (2017-2022)
12.2 Global Antibody Drug Conjugate Production, Consumption, Import and Export Forecast by Region (2017-2022)
  12.2.1 North America Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Antibody Drug Conjugate Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Antibody Drug Conjugate Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Antibody Drug Conjugate Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology/Research Approach
  14.1.1 Research Programs/Design
  14.1.2 Market Size Estimation
  14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
  14.2.1 Secondary Sources
  14.2.2 Primary Sources
14.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Antibody Drug Conjugate
Figure Global Antibody Drug Conjugate Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2012-2022)
Figure Global Antibody Drug Conjugate Production Market Share by Types (Product Category) in 2016
Figure Product Picture of Adcetris
Table Major Manufacturers of Adcetris
Figure Product Picture of Kadcyl
Table Major Manufacturers of Kadcyl
Figure Product Picture of Other
Table Major Manufacturers of Other
Figure Global Antibody Drug Conjugate Consumption (K Units) by Applications (2012-2022)
Figure Global Antibody Drug Conjugate Consumption Market Share by Applications in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Pharmaceutical Company Examples
Table Key Downstream Customer in Pharmaceutical Company
Figure Research Institutions Examples
Table Key Downstream Customer in Research Institutions
Figure Global Antibody Drug Conjugate Market Size (Million USD), Comparison (K Units) and CAGR (%) by Regions (2012-2022)
Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antibody Drug Conjugate Revenue (Million USD) Status and Outlook (2012-2022)
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) Status and Outlook (2012-2022)
Figure Global Antibody Drug Conjugate Major Players Product Capacity (K Units) (2012-2017)
Table Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers (2012-2017)
Table Global Antibody Drug Conjugate Capacity Market Share of Key Manufacturers (2012-2017)
Figure Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers in 2016
Figure Global Antibody Drug Conjugate Capacity (K Units) of Key Manufacturers in 2017
Figure Global Antibody Drug Conjugate Major Players Product Production (K Units) (2012-2017)
Table Global Antibody Drug Conjugate Production (K Units) of Key Manufacturers (2012-2017)
Table Global Antibody Drug Conjugate Production Share by Manufacturers (2012-2017)
Figure 2016 Antibody Drug Conjugate Production Share by Manufacturers
Figure 2017 Antibody Drug Conjugate Production Share by Manufacturers
Figure Global Antibody Drug Conjugate Major Players Product Revenue (Million USD) (2012-2017)
Table Global Antibody Drug Conjugate Revenue (Million USD) by Manufacturers (2012-2017)
Table Global Antibody Drug Conjugate Revenue Share by Manufacturers (2012-2017)
Table 2016 Global Antibody Drug Conjugate Revenue Share by Manufacturers
Table 2017 Global Antibody Drug Conjugate Revenue Share by Manufacturers
Table Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers (2012-2017)
Figure Global Market Antibody Drug Conjugate Average Price (USD/Unit) of Key Manufacturers in 2016
Table Manufacturers Antibody Drug Conjugate Manufacturing Base Distribution and Sales Area
Table Manufacturers Antibody Drug Conjugate Product Category
Figure Antibody Drug Conjugate Market Share of Top 3 Manufacturers
Figure Antibody Drug Conjugate Market Share of Top 5 Manufacturers
Table Global Antibody Drug Conjugate Capacity (K Units) by Region (2012-2017)
Figure Global Antibody Drug Conjugate Capacity Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugate Capacity Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Capacity Market Share by Region
Table Global Antibody Drug Conjugate Production by Region (2012-2017)
Figure Global Antibody Drug Conjugate Production (K Units) by Region (2012-2017)
Figure Global Antibody Drug Conjugate Production Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Production Market Share by Region
Table Global Antibody Drug Conjugate Revenue (Million USD) by Region (2012-2017)
Table Global Antibody Drug Conjugate Revenue Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugate Revenue Market Share by Region (2012-2017)
Table 2016 Global Antibody Drug Conjugate Revenue Market Share by Region
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) and Growth Rate (2012-2017)
Table Global Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table North America Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Europe Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table China Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Japan Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Southeast Asia Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table India Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Table Global Antibody Drug Conjugate Consumption (K Units) Market by Region (2012-2017)
Table Global Antibody Drug Conjugate Consumption Market Share by Region (2012-2017)
Figure Global Antibody Drug Conjugate Consumption Market Share by Region (2012-2017)
Figure 2016 Global Antibody Drug Conjugate Consumption (K Units) Market Share by Region
Table North America Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table Europe Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table China Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table Japan Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table Southeast Asia Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table India Antibody Drug Conjugate Production, Consumption, Import & Export (K Units) (2012-2017)
Table Global Antibody Drug Conjugate Production (K Units) by Type (2012-2017)
Table Global Antibody Drug Conjugate Production Share by Type (2012-2017)
Figure Production Market Share of Antibody Drug Conjugate by Type (2012-2017)
Figure 2016 Production Market Share of Antibody Drug Conjugate by Type
Table Global Antibody Drug Conjugate Revenue (Million USD) by Type (2012-2017)
Table Global Antibody Drug Conjugate Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Antibody Drug Conjugate by Type (2012-2017)
Figure 2016 Revenue Market Share of Antibody Drug Conjugate by Type
Table Global Antibody Drug Conjugate Price (USD/Unit) by Type (2012-2017)
Figure Global Antibody Drug Conjugate Production Growth by Type (2012-2017)
Table Global Antibody Drug Conjugate Consumption (K Units) by Application (2012-2017)
Table Global Antibody Drug Conjugate Consumption Market Share by Application (2012-2017)
Figure Global Antibody Drug Conjugate Consumption Market Share by Applications (2012-2017)
Figure Global Antibody Drug Conjugate Consumption Market Share by Application in 2016
Table Global Antibody Drug Conjugate Consumption Growth Rate by Application (2012-2017)
Figure Global Antibody Drug Conjugate Consumption Growth Rate by Application (2012-2017)
Table Seattle Genetics/Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Seattle Genetics/Takeda Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Seattle Genetics/Takeda Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Roche Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Roche Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table ImmunoGen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ImmunoGen Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Production Market Share (2012-2017)
Figure ImmunoGen Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Immunomedics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Immunomedics Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Pfizer Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Pfizer Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Celldex Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celldex Therapeutics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Celldex Therapeutics Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Millennium Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Millennium Pharmaceuticals Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Millennium Pharmaceuticals Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Bayer HealthCare Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer HealthCare Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Bayer HealthCare Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Mersana Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mersana Therapeutics Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Mersana Therapeutics Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Heidelberg Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Heidelberg Pharma Antibody Drug Conjugate Capacity, Production (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Production Growth Rate (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Production Market Share (2012-2017)
Figure Heidelberg Pharma Antibody Drug Conjugate Revenue Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody Drug Conjugate
Figure Manufacturing Process Analysis of Antibody Drug Conjugate
Figure Antibody Drug Conjugate Industrial Chain Analysis
Table Raw Materials Sources of Antibody Drug Conjugate Major Manufacturers in 2016
Table Major Buyers of Antibody Drug Conjugate
Table Distributors/Traders List
Figure Global Antibody Drug Conjugate Capacity, Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antibody Drug Conjugate Price (Million USD) and Trend Forecast (2017-2022)
Table Global Antibody Drug Conjugate Production (K Units) Forecast by Region (2017-2022)
Figure Global Antibody Drug Conjugate Production Market Share Forecast by Region (2017-2022)
Table Global Antibody Drug Conjugate Consumption (K Units) Forecast by Region (2017-2022)
Figure Global Antibody Drug Conjugate Consumption Market Share Forecast by Region (2017-2022)
Figure North America Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure North America Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table North America Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Europe Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Europe Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure China Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure China Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table China Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Japan Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Japan Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Southeast Asia Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Figure India Antibody Drug Conjugate Production (K Units) and Growth Rate Forecast (2017-2022)
Figure India Antibody Drug Conjugate Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table India Antibody Drug Conjugate Production, Consumption, Export and Import (K Units) Forecast (2017-2022)
Table Global Antibody Drug Conjugate Production (K Units) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugate Production (K Units) Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugate Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody Drug Conjugate Revenue Market Share Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugate Price Forecast by Type (2017-2022)
Table Global Antibody Drug Conjugate Consumption (K Units) Forecast by Application (2017-2022)
Figure Global Antibody Drug Conjugate Consumption (K Units) Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source